Abstract TDP-43 (TAR DNA-binding protein 43) is an RNAbinding protein implicated in RNA metabolism at several levels. Even if ubiquitously expressed, it is considered as a neuronal activity-responsive factor and a major signature for neurological pathologies, making the comprehension of its activity in the nervous system a very challenging issue. TDP-43 has also been described as an accessory component of the Drosha-DGCR8 (DiGeorge syndrome critical region gene 8) microprocessor complex, which is crucially involved in basal and tissue-specific RNA processing events. In the present study, we exploited in vitro neuronal differentiation systems to investigate the TDP-43 demand for the microprocessor function, focusing on both its canonical microRNA biosynthetic activity and its alternative role as a post-transcriptional regulator of gene expression. Our findings reveal a novel role for TDP-43 as an essential factor that controls the stability of Drosha protein during neuronal differentiation, thus globally affecting the production of microRNAs. We also demonstrate that TDP-43 is required for the Drosha-mediated regulation of Neurogenin 2, a master gene orchestrating neurogenesis, whereas posttranscriptional control of Dgcr8, another Drosha target, resulted to be TDP-43-independent. These results implicate a previously uncovered contribution of TDP-43 in regulating the abundance and the substrate specificity of the microprocessor complex and provide new insights into TDP-43 as a key player in neuronal differentiation.
Introduction
For its nature of neuronal activity-responsive factor [1] and hallmark of neurodegenerative diseases [2] , TAR DNAbinding protein has recently become the focus of intense interest in the fields of neuronal physiology and pathology.
Mutations within the gene encoding TDP-43 have been linked to neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal lobar dementia (FTLD) [3] [4] [5] [6] [7] . In these pathologies, TDP-43 is mis-localised from its predominant nuclear localization to the cytoplasm where it forms ubiquitinpositive inclusions leading, at the same time, to loss of normal nuclear TDP-43 function and to toxic cytoplasmic gain of function [8] . To understand the contribution of TDP-43 to the neurodegenerative process, several mouse models over-expressing TDP-43 have been generated that display motor neuron disease-like symptoms; nevertheless, the nuclear TDP-43 clearance and the appearance of cells with cytoplasmic TDP-43 inclusions, at later stages of pathogenesis, implies that the disease phenotype could be due to the concomitant occurrence of both events [9] . Recently, targeted depletion of TDP-43 expression in the mouse spinal cord motor neurons has shown that loss of TDP-43 function is sufficient and could be one of the major causes leading to TDP-43-linked ALS [10, 11] .
Originally identified as a transcription factor [12] , TDP-43 was subsequently described to regulate RNA splicing [13] stability [14, 15] , transport and translation [16, 17] .
In the last few years, a role in microRNA (miRNA) biogenesis has also been highlighted. In particular, TDP-43 was described as a factor associated with the nuclear Drosha/ DGCR8 (DiGeorge syndrome critical region gene 8) microprocessor [18] and cytoplasmic Dicer [19] complexes, involved in miRNA processing. By exploring the role of TDP-43 in undifferentiated cell lines, it was shown to contribute to the production of a subset of miRNAs [13, 20] . Moreover, participation of TDP-43 in neuronal outgrowth, by facilitating miR-132 production, was shown [20] .
Since miRNAs are crucially implicated in neuronal differentiation [21] and since diseased neurons show dramatic loss of nuclear TDP-43 staining [22] , investigating the nuclear contribution of TDP-43 to the miRNA biogenesis during in vitro neuronal differentiation offers a convenient entry point for exploring the impact of TDP-43 on normal and pathological differentiation. To realize the full implications of TDP-43 in microprocessor activity, we also investigated its possible participation in the recently underscored alternate function of Drosha complex in the regulation of the cellular proteome [23] [24] [25] [26] [27] [28] .
We find that during in vitro neuronal differentiation, when the levels of Drosha and DGCR8 strongly decrease, TDP-43 is crucial for controlling the microprocessor abundance. In fact, the loss of TDP-43 caused the destabilization of a conspicuous amount of Drosha protein, with the consequent downregulation of the entire miRNA repertoire. Furthermore, we show that, in the same condition, TDP-43 is also essential for the Drosha-mediated control of Neurogenin 2 , a master neurogenic gene, whereas it is dispensable for posttranscriptional regulation of Dgcr8 , another Drosha target. These data, while indicating an additional role for TDP-43 in microprocessor substrate recognition, underscore its implication in the control of Neurogenin 2 -dependent neuronal differentiation circuit.
Materials and Methods
Cell Culture and Transfections SK-N-BE(2)-C cells, from ATCC (Cat. No. CRL-2268), were cultured in RPMI medium 1640 (Gibco) supplemented with 10 % fetal bovine serum, L -glutamine and penicillin/ streptomycin (Gibco). SH-SY5Y cells were cultured in DMEM-F12 medium (Invitrogen) supplemented with 10 % fetal bovine serum, L -glutamine and penicillin/streptomycin (Gibco). Both cell lines were induced to differentiate with 10 μM all-trans-retinoic acid (Sigma-Aldrich).
TDP-43 siRNAs (5′-AGGCUCAUCUUGGCUUUGCTT-3′), Drosha siRNAs (5′-AACGAGTAGGCTTCGTGACTT-3′) and control siRNAs (AllStars Neg. Control siRNAs-Cat. No. 1027281) were purchased from Qiagen. Dicer siRNAs (D-003483-01) are from Dharmacon. SK-N-BE and SH-SY5Y cells were transiently transfected, in absence or in presence of RA, by using Lipofectamine and Plus Reagent (Invitrogen) in OPTI-MEM I medium (Gibco) according to manufacturer's directions. Cells were transfected for 3, 4 or 6 days with siRNAs at a final concentration of 100 nM.
For the proteasome inhibition studies, siRNAs transfected cells (3 days) were also treated for 24 h with 10 μM MG-132 (Z-Leu-Leu-Leu-al) (Sigma) or its vehicle dimethyl sulfoxide (DMSO) (Sigma).
Cell counting was performed by using a Countess Automated Cell Counter (Invitrogen). TDP-43 knockdown was obtained by Mission Lentiviral  shRNA clone targeting TDP-43 (TRCN000016040) . Mission Lentiviral Non-Targeting shRNA clone SHC002 was used as a control (Sigma-Aldrich). Lentiviral particles were prepared according to the manufacturer's specifications. Infection of SK-N-BE cell lines was performed as previously described [29] .
Stable Cell Lines Generation
Plasmid Construction GST-TDP-43: TDP-43 ORF was PCR amplified from total SK-N-BE cell cDNA with the oligolucleotides TDP-43_Up_WT
and inserted between Bam HI and NotI restriction sites of pGEX-4T-1 vector (Amersham Biosciences).
Oligonucleotides (Sequences Complementary to Exonic Regions)
qRT-PCR analysis:
Oligonucleotides used for Neurog2 and pre-GAPDH (glyceraldehyde-3-phosphate dehydrogenase; for RIP analysis), TDP-43 and Dicer mRNA and microRNAs amplification were purchased from Qiagen. RT-PCR analysis:
Oligonucleotides for Dcp1a, Dlg5, Snx12, Ino80e, Hoxa7 were as described [28] ; oligonucleotides for Eno1, Brd2, Mbnl1, Wipi2 were as described [26] .
RNA Extraction and Analysis
Total RNA was extracted using miRNeasy Mini Kit (Qiagen). Northern blot analyses were performed as previously described (27) employing 32P-labeled DNA oligonucleotides complementary to the sequence of mature miR-124, miR-9, miR125b, let-7b, miR-181a and U2 snRNA as probes.
For quantitative real-time PCR (qRT-PCR) assays, cDNA was obtained using miScript Reverse Transcription Kit (Qiagen) or SuperScriptTM III First-Strand Synthesis SuperMix (Invitrogen) for miRNA or mRNA expression studies, respectively. The qPCR detection was performed using miScript SYBR-Green PCR Kit (Qiagen) on a 7500 Fast Real-Time PCR (Applied Biosystem). The relative expression levels of miRNAs and mRNAs were normalized over SCARNA17 and GAPDH levels, respectively.
For Drosha isoforms determination and Neurog2 expression analysis, the same cDNAs were analyzed through semiquantitative reverse transcriptase-PCR (RT-PCR), using the specific oligonucleotides listed above. Unsaturated amplification reactions were agarose-separated, the fractionation pattern was revealed by ChemiDoc XRS+ Molecular Imager (Bio-Rad) and band intensity was estimated through the Image Lab (Beta1) software.
miRNA High-Throughput Analysis
The Applied Biosystems TaqMan® microRNA Arrays A and B (Applied Biosystems) were used to measure miRNA expression according to the manufacturer's instructions. cDNA synthesis was carried out with the TaqMan® MicroRNA Reverse Transcription Kit (Applied Biosystems) by using 750 ng of total RNA as a template. Amplification signal detection was carried out using the Applied Biosystems 7900HT Fast Real-Time PCR System with all samples run in duplicate. The values obtained were normalized for mammalian U6 snRNA (MammU6-4395470). Two independent high-throughput qRT-PCR experiments were carried out and replicates were omitted when undetermined (C t ≥40). Average fold differences below 0.8 and above 1.5 were considered to represent a significant difference between treated and untreated cells.
RNA Immunoprecipitation Assay
SH-SY5Y cells were grown with or without RA as described above. Nuclei were isolated in PBS 0.2× (supplemented with 0.25 M sucrose, 8 mM Tris-HCl pH 7.5, 4 mM MgCl 2 , 0.8 % Triton X-100) and disrupted in RIP buffer (150 mM KCl, 25 mM Tris pH 7.4, 5 mM EDTA, 0.5 mM DTT, 0.5 % NP-40 1× PIC, 1 mM PMSF, 100 U/ml RNAsin [Promega]). Nuclear extracts were incubated with TDP-43 (10 μg) of or DGCR8 (5 μg) antibody (or IgG, as control) and immunoprecipitated with ProteinA/G-sepharose resin (Pierce). Immunoprecipitated RNA was extracted by QIAZOL (Qiagen) and aliquots were retrotranscribed and analyzed by qRT-PCR using specific oligos for Neurog2, TDP-43, Dgcr8 and Tubulin-β1. Enrichments were reported as difference between Immunoprecipitation and Bead values, normalized over the corresponding input.
Immunoblotting
Whole-cell protein extracts were prepared from cells lysed in RIPA buffer (50 mM Tris-HCl (pH 8), 150 mM EGTA, 150 mM NaCl, 50 mM NaF, 10 % glycerol, 1.5 mM MgCl 2 , 1 % Triton and a protease inhibitor mixture; Roche Diagnostics), whereas insoluble pellet was treated with denaturing buffer (100 mM TrisHCl pH 7.4), 1 mM EDTA, 2 % SDS and a protease inhibitor mixture; Roche Diagnostics). Immunoblotting analyses were performed as previously described [30] . Dicer, GAPDH and Actinin antibodies were from Santa Cruz Biotechnology (sc-30226, sc-32233 and sc-15335, respectively), REST antibody from Millipore (07-579), NGN2, Drosha, DGCR8 antibodies from Abcam (ab109236, ab12286 and ab90579, respectively), ID2, N-Myc and Vgf antibody were used as previously described [30] ; p27 antibody was from BD Biosciences and TDP-43 antibody was kindly provided by Dr. E. Buratti (ICGEB, Trieste, Italy). Each immunoblot reported constitutes a representative example of at least three biological replicates. All the experiments were quantified through the Image Lab Software (release 3.0.1) launched over ".scn" files, generated directly during the acquisition procedure (by ChemiDoc XRS+ scanner), without any image conversion and/or manipulation. Possible saturated signals (out of linear range) leading to erroneous measurements are recognized and highlighted during the chemiluminescence revelation process by the instrument itself, thus allowing to discard over-exposed bands from quantifications.
Co-immunoprecipitation
Co-immunoprecipitation was performed using Immunoprecipitation kit-Dynabeads Protein G (Invitrogen) according to manufacturer's instructions. To obtain the nuclear extracts, the cell pellets were resuspended with Buffer A (Tris-HCl, pH 8, 20 mM, NaCl 10 mM, MgCl 2 3 mM, Igepal 0.1 %, glycerol 10 %, EDTA 0.2 mM) supplemented with protease inhibitor (Roche) and after centrifugation the nuclei were resuspended in Buffer C (Tris-HCl pH 8 20 mM, NaCl 400 mM, glycerol 20 %, DTT 1 mM) supplemented with protease inhibitor (Roche). After three cycles of incubation in liquid nitrogen followed by incubation at 37°C the nuclear extract was recovered by centrifugation.
GST Pull-down Drosha ORF for in vitro translation (performed by TnT-coupled Reticulocyte Lysate System kit, Promega) was amplified from SK-N-BE cell cDNA using oligos T7-DroshaCDS_fw ( G A A T T A A T A C G A C T C A C T A T A G G GATGATGCAGGGAAACAC) and DroshaCDS_rev (TTATTTCTTGATGTCTTCAGTCTC). The GST pull-down experiment was carried out as described by Morlando et al. [31] .
Statistics
Statistical significance was determined by two-tailed Student's t-tests. A p value <0.05 was considered statistically significant. Data shown here are the mean ± SEM from at least three experiments unless otherwise indicated.
Results
Knockdown of TDP-43 Globally Affects miRNA Production in NB Differentiating Cells TDP-43 knockdown was carried out in human neuroblastoma (NB)-derived SK-N-BE cell line, both in proliferating and in differentiating conditions. Neuronal differentiation was triggered by treatment with retinoic acid (RA) [32] , which induces cell growth arrest and the modulation of several neuronal differentiation markers ( Fig. S1a and b) .
Untreated or RA-treated NB cells were transfected with siRNAs against TDP-43 mRNA (Fig. 1a, lanes +) or control scrambled siRNAs (Fig. 1a, lanes -) , and TDP-43 levels were assessed by western blot. As shown in Fig. 1a , a considerable reduction of TDP-43 protein level both in untreated and in RAtreated NB cells (65 % and 90 % reduction, respectively) was obtained. RNA from the same samples was then used for miRNA expression profiling by Real-Time PCR (qRT-PCR). Figure 1b shows that the levels of the tested miRNAs were unaffected or slightly affected in untreated cells; conversely, they all were significantly reduced (from 45 % to 80 %) in RA-treated cells. The same profile was obtained in RA-treated cells when TDP-43 knockdown efficiency was lower (about 60 %; data not shown).
After we have confirmed these data in SH-SY5Y, another human-derived NB cell line (Fig. S2) [30, 33, 34] , the role of TDP-43 in miRNA biogenesis was further investigated through a global analysis of miRNA population. This analysis, carried out by the high-throughput qRT-PCR in SK-N-BE cells induced to neuronal differentiation, revealed that 90 % knockdown of TDP-43 caused a global downregulation of miRNAs (about 98 %, Fig. 1c and Table S1 , Fig. S3 ).
Knockdown of TDP-43 Leads to a Strong Reduction of Drosha Protein in NB Differentiating Cells
The levels of Drosha, DGCR8 and TDP-43 were evaluated at specific time points during the RA-induced differentiation of human SK-N-BE cells (Fig. S4) . Notably, we found that, while the levels of TDP-43 did not change upon RA treatment, those of both the microprocessor components strongly decreased at 3 days (a reduction of about 60 % for Drosha and 40 % for DGCR8). This profile suggested that the amount of the microprocessor complex may be limiting in differentiating versus proliferating cells.
We then addressed whether TDP-43 knockdown may alter the levels of the proteins involved in miRNA biogenesis. We found that the amount of both Drosha and DGCR8, as well as Dicer, were unaffected in undifferentiated SK-N-BE cells (Fig. 2a) . By contrast, knockdown of TDP-43 in RA-treated cells was accompanied by a strong reduction of Drosha levels (a 66 % decrease) and a concomitant slighter downregulation of DGCR8 (24 % decrease), whereas the levels of Dicer were not affected (Fig. 2b) . The same effect of TDP-43 depletion on Drosha and DGCR8 protein levels was observed in SH-SY5Y (Fig. S5a, b) .
To verify whether the observed Drosha protein reduction was due to an alteration of transcription and/or RNA stability, the levels of Drosha transcripts were evaluated in RA-treated SK-N-BE cells knocked down for TDP-43 relative to control cells. Based on the annotated Drosha splicing isoforms, derived from UCSC genome browser (http://genome.ucsc.edu/), forward and reverse primers common to all the annotated transcripts or specific for the individual mRNA isoforms were designed. As shown in Fig. 3a , qRT-PCR on total RNA using the primers common to all transcripts indicated that the strong reduction of Drosha protein was not accompanied by a corresponding reduction of Drosha mRNA level, which decreased by only 15 % in cells depleted for TDP-43. This result was also confirmed in SH-SY5Y cell line (Fig. S5c) . In agreement, also the deeper analysis of the individual splicing isoforms, carried out by RT-PCR, did not show any qualitative or quantitative difference between cells knocked down for TDP-43 and control cells (Fig. 3b-d) suggesting that TDP-43-dependent Drosha downregulation does not occur at the RNA level. This conclusion was further supported by the lack of binding between TDP-43 and Drosha transcript, as demonstrated by RNA Immunoprecipitation (RIP) assay (Fig. 3e) .
The possibility that miRNA-mediated translation repression could be responsible for Drosha protein decrease was also considered. Since a very small fraction of miRNAs was upregulated following TDP-43 depletion, we searched for their putative target sites on Drosha transcripts interrogating several miRNA databases. In particular, miRanda (http://www.microrna.org/ microrna/home.do), TargetScan (http://www.targetscan.org), DIANA microT (http://diana.cslab.ece.ntua.gr) and miRTarBase (http://mirtarbase.mbc.nctu.edu.tw) were utilized to analyze the 3′ untranslated region (3′UTR), whereas the 5′UTR and coding sequences were tested through miRWalk database (http://www. umm.uni-heidelberg.de/apps/zmf/mirwalk/index.html). These in silico analyses showed the absence of putative target sites for the upregulated miRNAs on Drosha transcripts.
Altogether, these results indicate that TDP-43 may control Drosha levels during in vitro NB cell differentiation, and that this control is mainly exerted at the protein level. This conclusion, consistent with the reported physical association of TDP-43 with the Drosha complex [18, 20] that we confirmed in our model system (Fig. 4a) , is further supported by the demonstration of a direct interaction between TDP-43 and Drosha, as shown by the GST pull-down assay reported in Fig. 4b .
Drosha Protein Level is Rescued in TDP-43 Depleted Cells After Proteasome Inhibition
The observed decrease of Drosha protein levels after TDP-43 knockdown may be due to the microprocessor complex (Fig. 5) . To this aim, we treated cells with MG-132, one of the most commonly used inhibitor of the proteasome degradative pathway [36] . As control, we analyzed the levels of p27, known to significantly increase after MG-132 treatment [37] .
In RA-treated cells transfected with control scrambled siRNAs (Fig. 5, lanes siCTRL) the level of the Drosha protein increased after MG-132 treatment with respect to mocktreated cells, suggesting a proteasome-dependent Drosha degradation. In the same conditions, the level of TDP-43 did not increase; this is due to the already described insolubility of TDP-43 after MG-132 treatment [38] , as confirmed by the recovery of TDP-43 by denaturing extraction of the insoluble pellet (Fig. S6) .
Notably, Fig. 5 shows that the Drosha protein levels, which dropped down in mock-treated cells depleted for TDP-43 (lane siTDP-43/mock), were significantly rescued when cells were grown in the presence of MG-132 (lane siTDP-43/MG-132). These results led us to conclude that Drosha turnover relies on the proteasome degradative pathway and that its stability is strongly affected by TDP-43 depletion during in vitro neuronal differentiation. Apart from miRNA processing, an alternate function for Drosha and the microprocessor complex in the regulation of the cellular transcriptome has been underscored. Several hairpin-containing mRNAs whose levels are negatively regulated by Drosha have been identified [26, 28] . Besides the first detected mRNA substrate, Dgcr8 [23] , that is involved in an autoregulatory feedback circuit, novel endogenous sets of RNA targets were identified in non-neuronal cell types [26, 28] . In addition, a crucial role for Drosha complex in regulating neurogenesis, by modulating mouse Neurogenin 2 RNA (Neurog2 ) expression through 3′UTR cleavage, has been highlighted [27] . A computational prediction of human Neurog2 3′UTR structure strongly suggested the occurrence of a similar control mechanism (Fig. S7 , UNAFold Web Server, http://www.bioinfo.rpi.edu/applications/mfold).
However, since it has been shown that the mRNA-cleaving activity of Drosha may vary between cell types [26] , we first addressed whether Drosha exerted its regulative function in our model system. We analyzed the expression of 12 different mRNA species in RA-treated NB cells depleted for Drosha. Notably, we found that only two mRNAs, Dgcr8 and Neurog2, were derepressed by Drosha deficiency while the other ten species tested were not expressed or not upregulated (Fig. S8) . In particular, the levels of Dgcr8 increased by about 2.5-folds and those of Neurog2 by about 2.9-folds in RAtreated cells depleted for Drosha with respect to control cells (Fig. 6a) .
Based on these results and on the previous observation that Drosha protein was regulated by TDP-43 only during differentiation (Fig. 2) , we performed RNAi against TDP-43 in RAtreated cells and analyzed Neurog2 and Dgcr8 expression levels. Notably, a 2.8-fold increase of Neurog2 mRNA was observed in TDP-43 knockdown cells relative to control cells (an alternative TDP-43 RNAi assay is reported in Fig. S9 ), whereas the levels of Dgcr8 mRNA were not affected at all (Fig. 6b) .
Since we excluded that TDP-43-dependent microRNA abatement was responsible for such Neurog2 induction (Fig. S10) , a possible explanation is that TDP-43 affects the affinity of Drosha complex for Neurog2 mRNA substrate. As a supporting evidence, the ability of TDP-43 to bind Neurog2 and Dgcr8 mRNAs was verified through a RIP assay, carried out using a nuclear lysate from differentiating SH-SY5Y cells.
We employed tubulin-β1 mRNA as a negative control and TDP-43 mRNA, whose concentration is auto-regulated by TDP-43 itself [14, 39] , as a positive control. Remarkably, we found that TDP-43 was physically associated with Neurog2 transcript, whereas Dgcr8 mRNA was not bound (Fig. 6c) . This suggests that TDP-43 may drive the microprocessor complex to distinct RNA substrates. We performed a RIP assay for DGCR8 in stable cell lines expressing shRNAs against TDP-43: in agreement with our hypothesis, we found that the binding of the microprocessor to Neurog2 mRNA occurred only in the presence of TDP-43, whereas the binding of Dgcr8 mRNAwas TDP-43 insensitive. These results demonstrate that the microprocessor requires TDP-43 for specific target recognition.
An increase of about 2-folds of the Ngn2 protein levels (Fig. 6e) was also highlighted in RA-treated cells knocked down for TDP-43. We next asked whether such Ngn2 upregulation caused the activation of its target and downstream effector NeuroD1 [27] whose levels, similarly to Neurog2, decreased in RA-treated cells (Fig. S11a, b) . We found that in differentiating cells, TDP-43 knockdown caused an increase of Neurod1 mRNA levels by about 70 % (Fig. 6f) , even though such regulation did not rely on physical association between TDP-43 and Neurod1 mRNA (Fig. S12) .
Discussion
Despite its nature of nuclear, ubiquitously expressed protein, TDP-43 is considered as a neuronal activity-responsive factor that may function as a modulator of neuronal plasticity [1] . Analysis of its distribution in mouse brain showed that it is enriched in the hippocampal neurons, where it resides in the neuronal dendrites, and that it increases in the cultured neurons upon specific stimuli simulating the learning/memory process [1] .
In line with its physiological role in the nervous system, TDP-43 has also been underscored as a major signature of neurodegeneration, occurring in diseases such as ALS and FTLD. The common feature of these pathologies is the mislocalization of the mutated protein to the cytoplasm, with consequent loss of its normal nuclear function. A similar behavior has also been demonstrated for FUS (fused in sarcoma), another ALS-associated RNA-binding protein [10, 11, 40] . Among its nuclear activities, and besides the established role in RNA splicing, TDP-43 has been involved in miRNA biogenesis [13, 20] as an auxiliary component of the microprocessor complex [18] . Such association seems to be even more intriguing in the light of the recent discovery of an alternate function for Drosha complex in recognizing and cleaving many stem-loop structure-containing proteincoding messenger RNAs [26, 28] . In particular, the microprocessor controls neurogenesis by regulating the expression of Neurog2 mRNA, a proneural transcription factor critical for neurogenic differentiation [27] . Therefore, unveiling the functional link between TDP-43 and the microprocessor will advance the understanding of the regulatory and disease mechanisms in which TDP-43 is involved.
In this study, we demonstrate for the first time that TDP-43 crucially intervenes in neuronal differentiation by controlling Drosha complex at different levels. We highlighted this neuronal regulatory role through loss-of-function experiments carried out in a model system of in vitro neuronal differentiation, a condition where the levels of both Drosha and DGCR8 strongly decrease, which makes the amount of the microprocessor complex limiting. In this context, the absence of TDP-43 led to the proteasome-dependent destabilization of a considerable amount of Drosha protein. This may be due to a different protein composition (absence or presence of stem or neuronal factors) of the microprocessor in growing versus differentiating cells. In turn, this would lead to a differential susceptibility of Drosha to the depletion of TDP-43, which may justify its role onto Drosha stability only upon differentiation stimulus.
The direct interaction between TDP-43 and Drosha allows us to speculate that TDP-43 might affect Drosha by protecting it from ubiquitin-dependent degradation. Drosha destabilization, in turn, elicited a global downregulation of microRNA biosynthesis that, in combination with the ongoing microRNA degradation and with their dilution upon cell division (Fig. S13) , may explain the substantial decrease of microRNA levels. Fig. 7 Schematic representation of TDP-43 involvement in a regulatory cascade controlling neuronal differentiation. Microprocessor component levels progressively reduced along in vitro neuronal differentiation: in such sensitized context, TDP-43 plays a role in the stabilization of Drosha protein (1), which impacts onto global microRNA biosynthesis (2) . TDP-43 also participates in post-transcriptional regulation of the Drosha target Neurog2 mRNA both directly, by association with Neurog2 mRNA (3), and indirectly, by controlling Drosha stability (4). In turn, Ngn2 transcriptionally controls NeuroD1 expression (5), whose steady state levels are also modulated by the microprocessor itself (6) . Finally, NeuroD1 induces expression of downstream neuronal-related genes driving neuronal differentiation (7) Besides this first level of regulation, exerted on the microprocessor machinery abundance, TDP-43 is also implicated in Drosha substrate recognition. In fact, during neuronal differentiation, TDP-43 was dispensable for the Drosha-mediated DGCR8 regulation, whereas it was essential for Neurog2 expression control. These findings, together with the physical association of TDP-43 with Neurog2 mRNA and not with Dgcr8 , led us to propose that, in cells undergoing neuronal differentiation, TDP-43 may be the factor that regulates the affinity of Drosha complex for Neurog2 mRNA. This result perfectly agrees with the recent discovery that DGCR8 alone is not responsible for specific RNA target recognition by the microprocessor [41] and suggests that distinct microprocessor complexes may operate on different RNA substrates based on TDP-43 demands.
Neurog2 expression occurs early in proliferating neural precursor cells and, upon loss of stem-cell status, the protein induces the expression of multiple downstream direct targets. Among these, NeuroD1 represents a key player in driving neuronal differentiation, since it induces the expression of neuronal differentiation-related genes [42] . NeuroD1, whose expression decreases as neurogenesis proceeds [43] , is regulated not only at the transcriptional level by Ngn2, but also post-transcriptionally as a Drosha complex substrate [27] . Here we demonstrate that, during differentiation, TDP-43 contributed to modulate NeuroD1 expression by controlling the cellular levels of both its regulators, Ngn2 and Drosha (Fig. 7) .
In conclusion, we found that, while in growing cells TDP-43 cooperates with the microprocessor by selecting a subset of pri-miRNAs for Drosha cleavage [13, 20] , upon triggering of neuronal differentiation it behaves as an essential regulatory factor. It controls the abundance and the substrate-specificity of the microprocessor complex, thus guaranteeing the homeostatic control of miRNA biogenesis and the correct expression of Neurog2. By regulating Neurog2, a master neurogenic gene orchestrating a transcriptional regulatory cascade that directs undifferentiated neural precursor cells towards a neuronal fate, TDP-43 contributes to proper neuronal differentiation, possibly preventing aberrant accumulation of neurogenic factors.
Finally, our study, whose experimental loss-of-function design mimicked the TDP-43 nuclear clearance reported in ALS, would provide a toehold for understanding TDP-43 normal cellular function and suggest potential consequences of its deregulation in neurodegenerative disease.
